SCHEMBL23498281

SCHEMBL23498281

NC(=O)c1cn(C2CC2)c2nc(Cl)c(F)cc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.49
CHRM2 P08172 2/20 0.44
DRD1 P21728 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 2/20 0.43
POLB P06746 1/20 0.43
CHRM1 P11229 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
TOP2A P11388 5/20 0.43
TOP2B Q02880 5/20 0.43
KDM4E B2RXH2 2/20 0.42
LMNA P02545 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ABCC4 O15439 1/20 0.42
CSF1R P07333 2/20 0.40
PIK3CG P48736 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL500472 0.89 DPP4 (0.57) DPP4CHRM2DRD1ALDH1A1POLB
SCHEMBL17270378 0.88 DPP4 (0.48) DPP4CHRM2DRD1ALDH1A1POLB
SCHEMBL27789261 0.84 DPP4 (0.52) DPP4CHRM2DRD1ALDH1A1POLB
SCHEMBL5422476 0.82 ADRB2 (0.51) DPP4CHRM2DRD1KMT2AALDH1A1
SCHEMBL4774919 0.81 DPP4 (0.44) DPP4CHRM2DRD1ALDH1A1POLB
SCHEMBL27788932 0.79 DPP4 (0.41) DPP4CHRM2DRD1MEN1KMT2A
SCHEMBL27344629 0.79 DPP4 (0.48) DPP4CHRM2DRD1ALDH1A1POLB
SCHEMBL17537004 0.78 DPP4 (0.47) DPP4CHRM2DRD1ALDH1A1POLB
SCHEMBL16469268 0.78 DPP4 (0.38) DPP4CHRM2DRD1ALDH1A1POLB
SCHEMBL22774763 0.78 DPP4 (0.38) DPP4CHRM2DRD1TOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021116451-A1 HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2021-06-17 WO disclosed